Apellis (NASDAQ: APLS) insider to sell 3,371 shares after RSU vesting

Rhea-AI Filing Summary

Apellis Pharmaceuticals insider plans to sell additional shares under Rule 144. A notice was filed for the proposed sale of 3,371 shares of Apellis common stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of 73,371.17 and 126,525,218 shares outstanding.

The shares to be sold were acquired on 01/21/2026 through restricted stock vesting from the issuer as compensation. In the past three months, Mark J. Delong has already sold 1,780 shares for 39,493.22 on 01/13/2026 and 1,334 shares for 26,403.73 on 01/20/2026. By signing the notice, the seller represents that he is not aware of any undisclosed material adverse information about Apellis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3371	73371.17	126525218	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2026	Restricted Stock Vesting	Issuer			3371	01/21/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark J. Delong 100 Fifth Avenue Waltham MA 02451	Common	01/13/2026	1780	39493.22
Mark J. Delong 100 Fifth Avenue Waltham MA 02451	Common	01/20/2026	1334	26403.73

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for APLS disclose?

The filing discloses that an insider intends to sell 3,371 shares of Apellis common stock under Rule 144 on NASDAQ through Fidelity Brokerage Services, with an aggregate market value of 73,371.17.

How many Apellis (APLS) shares is Mark J. Delong planning to sell?

The notice covers a proposed sale of 3,371 shares of Apellis common stock, with an aggregate market value reported as 73,371.17.

How did the Apellis (APLS) insider acquire the shares being sold?

The 3,371 shares to be sold were acquired on 01/21/2026 as restricted stock that vested, described as compensation from the issuer.

What recent Apellis (APLS) stock sales has Mark J. Delong made?

During the past three months, he sold 1,780 shares of common stock on 01/13/2026 for gross proceeds of 39,493.22 and 1,334 shares on 01/20/2026 for gross proceeds of 26,403.73.

How many Apellis (APLS) shares are outstanding in this Form 144?

The notice states that 126,525,218 shares of Apellis common stock were outstanding, providing context for the size of the planned sale.

What representation does the Apellis (APLS) insider make in the Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Apellis that has not been publicly disclosed.